Plain-English translation of NCT06700876 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking for better ways to find tuberculosis (TB) early in people with end-stage kidney disease or kidney transplants. Researchers will use three different approaches — a blood test called an interferon-gamma release assay (IGRA), checking for TB symptoms, and chest X-rays — to see which methods work best at catching TB before it becomes active and dangerous.
People with serious kidney disease are at higher risk of developing tuberculosis, but TB is often found too late in this group. This study aims to find the best combination of simple, affordable tests to catch TB early, when it's still hidden and easier to treat.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic where you'll have blood drawn for an interferon-gamma release assay test, answer questions about any TB symptoms you may have, and have a chest X-ray taken. The entire visit should take a few hours, and there are no ongoing medications or lifestyle changes required — this is purely a screening and evaluation study to see which detection methods work best.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Thailand
National Research Council of Thailand
Enrollment target
~160 participants
Started
August 2024
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tanaya Siripoon, M.D.
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.